spacer
home > ict > winter 2020 > keeping trials connected
PUBLICATIONS
International Clinical Trials

Keeping Trials Connected




Staying up to date with the latest advances in cellular technologies is exhausting at best. Sometimes, just keeping the acronyms straight can be too much to handle (see NBIoT, Cat-M1, and EC-GSM-IoT), let alone adding in the complications that come with supporting an international clinical trial deployment. If you havenít yet experienced these dynamics, just sit down with someone in your technical operations group and ask why device certification and cellular band support matter when it comes to clinical trials in Japan.

While itís true that connected clinical trials have moved from being a value differentiator to simply becoming an industry standard, it is estimated that most people live more than two hours away from a clinical study site. Connectivity dramatically shortens that distance, virtually. The ability to retain clinical trial participants increases dramatically with less reliance upon the study site.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Stephen Byrne currently serves as the EU Managing Director of KORE. With more than 20 years of experience in healthcare and medical device technology implementation, he brings a wealth of information relating to the complexities associated with European and global clinical trial deployments.
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement